Offering smoke-free alternatives to adult smokers can reduce the risk of harm. We believe that this approach should be supported by public health bodies, in addition to existing efforts to prevent smoking initiation and encourage cessation.
Progressive regulatory oversight can protect public health whilst simultaneously ensuring that adult smokers can access smoke-free products as well as accurate and non-misleading information about them. Access to such information is a common-sense approach to public health.
Modern regulation should take into account the novel nature of smoke-free products. It should ensure that specific quality and performance standards are met. Robust scientific evidence should demonstrate their reduced risk profile.
Our contribution so far
Our extensive assessment of Platform 1 has been submitted to regulatory bodies in several countries. We submitted a Modified Risk Tobacco Product (MRTP) Application to the US Food and Drug Administration in December 2016, as well as similar applications to regulatory authorities in several EU member states.